Download PDF
Semin Respir Crit Care Med 2013; 34(01): 087-094
DOI: 10.1055/s-0033-1333567
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Update on the Epidemiology of Pulmonary Nontuberculous Mycobacterial Infections

Brian A. Kendall
1   Department of Pathology, University of Utah, Salt Lake City, Utah
2   ARUP Laboratories, Salt Lake City, Utah
,
Kevin L. Winthrop
3   Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon
4   Division of Ophthalmology, Oregon Health and Science University, Portland, Oregon
5   Division of Public Health and Preventative Medicine, Oregon Health and Science University, Portland, Oregon
› Author Affiliations
Further Information

Publication History

Publication Date:
04 March 2013 (online)

    Permissions and Reprints

Abstract

For decades, the incidence of pulmonary nontuberculous mycobacteria (NTM) has been reported to be increasing, yet formal epidemiological evaluation of this notion has been lacking until recently. Defining the epidemiology of NTM has been more challenging than with Mycobacterium tuberculosis (MTB). Unlike MTB, NTM are soil and water organisms, and infection is thought to be acquired from the environment rather than transmitted from person-to-person, with very rare exceptions. Due to their nearly ubiquitous presence in municipal water supplies, exposure to NTM is common. Further, NTM can colonize the respiratory tract without causing disease. NTM disease is not reportable to public health authorities; therefore, epidemiological and surveillance data are not readily available. Nonetheless, the prevalence of pulmonary NTM disease has increased dramatically in the United States and globally over the past 3 decades. Mycobacterium avium complex (MAC) accounts for the majority of NTM infections worldwide, but there is significant regional variability of various species. Additionally, novel species have been implicated in several countries in NTM pulmonary disease.

Keywords

nontuberculous mycobacteria - epidemiology - Mycobacterium avium - Mycobacterium tuberculosis
 

  • References

  • 1 Aitken ML, Limaye A, Pottinger P , et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med 2012; 185 (2) 231-232
    CrossrefPubMedGoogle Scholar
  • 2 Feazel LM, Baumgartner LK, Peterson KL, Frank DN, Harris JK, Pace NR. Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci U S A 2009; 106 (38) 16393-16399
    CrossrefPubMedGoogle Scholar
  • 3 O'Brien RJ, Geiter LJ, Snider Jr DE. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis 1987; 135 (5) 1007-1014
    PubMedGoogle Scholar
  • 4 Centers for Disease Control and Prevention (CDC). Trends in tuberculosis—United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61 (11) 181-185
    PubMedGoogle Scholar
  • 5 Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA. A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest 1979; 75 (2) 120-125
    CrossrefPubMedGoogle Scholar
  • 6 Behr MA. Mycobacterium du jour: what's on tomorrow's menu?. Microbes Infect 2008; 10 (9) 968-972
    CrossrefPubMedGoogle Scholar
  • 7 Fogan L. PPD antigens and the diagnosis of mycobacterial diseases. A study of atypical mycobacterial disease in Oklahoma. Arch Intern Med 1969; 124 (1) 49-54
    CrossrefPubMedGoogle Scholar
  • 8 Griffith DE, Aksamit T, Brown-Elliott BA , et al; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175 (4) 367-416
    CrossrefPubMedGoogle Scholar
  • 9 Winthrop KL. Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist's view. Future Microbiol 2010; 5 (3) 343-345
    CrossrefPubMedGoogle Scholar
  • 10 Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax 2007; 62 (8) 661-666
    CrossrefPubMedGoogle Scholar
  • 10a Hernandez-Garduno E, Rodrigues M, Elwood RK. The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada. Int J Tuberc Lung Dis 2009; 13 (9) 1086-1093
    PubMedGoogle Scholar
  • 11 Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009; 49 (12) e124-e129
    CrossrefPubMedGoogle Scholar
  • 12 Winthrop KL, McNelley E, Kendall B , et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010; 182 (7) 977-982
    CrossrefPubMedGoogle Scholar
  • 13 Prevots DR, Shaw PA, Strickland D , et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010; 182 (7) 970-976
    CrossrefPubMedGoogle Scholar
  • 14 Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med 2012; 185 (8) 881-886
    CrossrefPubMedGoogle Scholar
  • 15 Billinger ME, Olivier KN, Viboud C , et al. Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis 2009; 15 (10) 1562-1569
    CrossrefPubMedGoogle Scholar
  • 16 Winthrop KL, Baxter R, Liu L , et al. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf 2011; 20 (3) 229-235
    CrossrefPubMedGoogle Scholar
  • 17 Kendall BA, Varley CD, Choi D , et al. Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA. Emerg Infect Dis 2011; 17 (3) 506-509
    CrossrefPubMedGoogle Scholar
  • 18 Satyanarayana G, Heysell SK, Scully KW, Houpt ER. Mycobacterial infections in a large Virginia hospital, 2001-2009. BMC Infect Dis 2011; 11: 113
    CrossrefPubMedGoogle Scholar
  • 19 Simmon KE, Brown-Elliott BA, Ridge PG , et al. Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USA. Emerg Infect Dis 2011; 17 (9) 1692-1700
    CrossrefPubMedGoogle Scholar
  • 20 Brown-Elliott BA, Wallace Jr RJ, Tichindelean C , et al. Five-year outbreak of community- and hospital-acquired Mycobacterium porcinum infections related to public water supplies. J Clin Microbiol 2011; 49 (12) 4231-4238
    CrossrefPubMedGoogle Scholar
  • 21 Simons S, van Ingen J, Hsueh PR , et al. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis 2011; 17 (3) 343-349
    CrossrefPubMedGoogle Scholar
  • 22 Thomson RM. NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 2010; 16 (10) 1576-1583
    CrossrefPubMedGoogle Scholar
  • 23 Lai CC, Tan CK, Chou CH , et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis 2010; 16 (2) 294-296
    CrossrefPubMedGoogle Scholar
  • 24 Lai CC, Tan CK, Lin SH , et al. Clinical significance of nontuberculous mycobacteria isolates in elderly Taiwanese patients. Eur J Clin Microbiol Infect Dis 2011; 30 (6) 779-783
    CrossrefPubMedGoogle Scholar
  • 25 Shen MC, Lee SS, Huang TS, Liu YC. Clinical significance of isolation of Mycobacterium avium complex from respiratory specimens. J Formos Med Assoc 2010; 109 (7) 517-523
    CrossrefPubMedGoogle Scholar
  • 26 Park YS, Lee CH, Lee SM , et al. Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis 2010; 14 (8) 1069-1071
    PubMedGoogle Scholar
  • 27 Shojaei H, Heidarieh P, Hashemi A, Feizabadi MM, Daei Naser A. Species identification of neglected nontuberculous mycobacteria in a developing country. Jpn J Infect Dis 2011; 64 (4) 265-271
    PubMedGoogle Scholar
  • 28 Khanum T, Rasool SA, Ajaz M, Khan AI. Isolation-drug resistance profile and molecular characterization of indigenous typical and atypical mycobacteria. Pak J Pharm Sci 2011; 24 (4) 527-532
    PubMedGoogle Scholar
  • 29 Shenai S, Rodrigues C, Mehta A. Time to identify and define non-tuberculous mycobacteria in a tuberculosis-endemic region. Int J Tuberc Lung Dis 2010; 14 (8) 1001-1008
    PubMedGoogle Scholar
  • 30 Moore JE, Kruijshaar ME, Ormerod LP, Drobniewski F, Abubakar I. Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006. BMC Public Health 2010; 10: 612
    CrossrefPubMedGoogle Scholar
  • 31 van Ingen J, Hoefsloot W, Dekhuijzen PN, Boeree MJ, van Soolingen D. The changing pattern of clinical Mycobacterium avium isolation in the Netherlands. Int J Tuberc Lung Dis 2010; 14 (9) 1176-1180
    PubMedGoogle Scholar
  • 32 Gitti Z, Mantadakis E, Maraki S, Samonis G. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece. Future Microbiol 2011; 6 (9) 1099-1109
    CrossrefPubMedGoogle Scholar
  • 33 Del Giudice G, Iadevaia C, Santoro G, Moscariello E, Smeraglia R, Marzo C. Nontuberculous mycobacterial lung disease in patients without HIV infection: a retrospective analysis over 3 years. Clin Respir J 2011; 5 (4) 203-210
    CrossrefPubMedGoogle Scholar
  • 34 Bicmen C, Coskun M, Gunduz AT, Senol G, Cirak AK, Tibet G. Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not?. New Microbiol 2010; 33 (4) 399-403
    PubMedGoogle Scholar
  • 35 Amorim A, Macedo R, Lopes A, Rodrigues I, Pereira E. Non-tuberculous mycobacteria in HIV-negative patients with pulmonary disease in Lisbon, Portugal. Scand J Infect Dis 2010; 42 (8) 626-628
    CrossrefPubMedGoogle Scholar
  • 36 Marusić A, Katalinić-Janković V, Popović-Grle S , et al. Mycobacterium xenopi pulmonary disease—epidemiology and clinical features in non-immunocompromised patients. J Infect 2009; 58 (2) 108-112
    CrossrefPubMedGoogle Scholar
  • 37 van Ingen J, Boeree MJ, de Lange WC , et al. Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis 2008; 14 (3) 385-389
    CrossrefPubMedGoogle Scholar
  • 38 Andréjak C, Lescure FX, Pukenyte E , et al; Xenopi Group. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax 2009; 64 (4) 291-296
    CrossrefPubMedGoogle Scholar
  • 39 Hoefsloot W, van Ingen J, de Lange WC, Dekhuijzen PN, Boeree MJ, van Soolingen D. Clinical relevance of Mycobacterium malmoense isolation in the Netherlands. Eur Respir J 2009; 34 (4) 926-931
    CrossrefPubMedGoogle Scholar
  • 40 Falkinham III JO, Norton CD, LeChevallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. Appl Environ Microbiol 2001; 67 (3) 1225-1231
    CrossrefPubMedGoogle Scholar
  • 41 Falkinham III JO. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis 2011; 17 (3) 419-424
    CrossrefPubMedGoogle Scholar
  • 42 Winthrop KL, Varley CD, Ory J, Cassidy PM, Hedberg K. Pulmonary disease associated with nontuberculous mycobacteria, Oregon, USA. Emerg Infect Dis 2011; 17 (9) 1760-1761
    CrossrefPubMedGoogle Scholar
  • 43 Martin EC, Parker BC, Falkinham III JO. Epidemiology of infection by nontuberculous mycobacteria, VII: Absence of mycobacteria in southeastern groundwaters. Am Rev Respir Dis 1987; 136 (2) 344-348
    CrossrefPubMedGoogle Scholar
  • 44 Maekawa K, Ito Y, Hirai T , et al. Environmental risk factors for pulmonary Mycobacterium avium-intracellulare complex disease. Chest 2011; 140 (3) 723-729
    CrossrefPubMedGoogle Scholar
  • 45 Olivier KN, Weber DJ, Wallace Jr RJ , et al; Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria, I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003; 167 (6) 828-834
    CrossrefPubMedGoogle Scholar
  • 46 Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis 2004; 4 (9) 557-565
    CrossrefPubMedGoogle Scholar
  • 47 Buijtels PC, van der Sande MA, Parkinson S, Verbrugh HA, Petit PL, van Soolingen D. Isolation of non-tuberculous mycobacteria at three rural settings in Zambia; a pilot study. Clin Microbiol Infect 2010; 16 (8) 1142-1148
    PubMedGoogle Scholar
  • 48 Buijtels PC, van-der-Sande MA, de-Graaff CS , et al. Nontuberculous mycobacteria, zambia. Emerg Infect Dis 2009; 15 (2) 242-249
    CrossrefPubMedGoogle Scholar
  • 49 Crump JA, van Ingen J, Morrissey AB , et al. Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg Infect Dis 2009; 15 (1) 53-55
    CrossrefPubMedGoogle Scholar
  • 50 McCarthy KD, Cain KP, Winthrop KL , et al. Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia. Am J Respir Crit Care Med 2012; 185 (9) 981-988
    CrossrefPubMedGoogle Scholar
  • 51 Lai CC, Tan CK, Cheng A , et al. Nontuberculous mycobacterial infections in cancer patients in a medical center in Taiwan, 2005-2008. Diagn Microbiol Infect Dis 2012; 72 (2) 161-165
    CrossrefPubMedGoogle Scholar
  • 52 Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004; 38 (9) 1261-1265
    CrossrefPubMedGoogle Scholar
  • 53 Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 2009; 15 (10) 1556-1561
    CrossrefPubMedGoogle Scholar
  • 54 Winthrop K, Baxter R, Liu L , et al. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis 2013; 72 (1) 37-42
    CrossrefPubMedGoogle Scholar
  • 55 Hojo M, Iikura M, Hirano S, Sugiyama H, Kobayashi N, Kudo K. Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy. Respirology 2012; 17 (1) 185-190
    CrossrefPubMedGoogle Scholar
  • 56 Behr MA, Falkinham III JO. Molecular epidemiology of nontuberculous mycobacteria. Future Microbiol 2009; 4 (8) 1009-1020
    CrossrefPubMedGoogle Scholar
  • 57 Koh WJ, Jeon K, Lee NY , et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 2011; 183 (3) 405-410
    CrossrefPubMedGoogle Scholar
  • 58 Pestel-Caron M, Arbeit RD. Characterization of IS1245 for strain typing of Mycobacterium avium. J Clin Microbiol 1998; 36 (7) 1859-1863
    PubMedGoogle Scholar
  • 59 Amonsin A, Li LL, Zhang Q , et al. Multilocus short sequence repeat sequencing approach for differentiating among Mycobacterium avium subsp. paratuberculosis strains. J Clin Microbiol 2004; 42 (4) 1694-1702
    CrossrefPubMedGoogle Scholar
  • 60 Roux AL, Catherinot E, Ripoll F , et al; Jean-Louis Herrmann for the OMA Group. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol 2009; 47 (12) 4124-4128
    CrossrefPubMedGoogle Scholar
  • 61 Chen CY, Chen HY, Chou CH, Huang CT, Lai CC, Hsueh PR. Pulmonary infection caused by nontuberculous mycobacteria in a medical center in Taiwan, 2005-2008. Diagn Microbiol Infect Dis 2012; 72 (1) 47-51
    CrossrefPubMedGoogle Scholar